These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2839121

  • 21. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
    Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, Blaese RM.
    J Clin Invest; 1984 Jun; 73(6):1789-95. PubMed ID: 6327772
    [Abstract] [Full Text] [Related]

  • 22. Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production.
    Rodriguez MA, Bankhurst AD, Williams RC, Troup GM, Stastny P.
    Clin Immunol Immunopathol; 1983 Apr; 27(1):96-109. PubMed ID: 6307569
    [Abstract] [Full Text] [Related]

  • 23. HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis.
    Toussirot E, Auger I, Roudier C, Luka J, Wendling D, Tiberghien P, Roudier J.
    Tissue Antigens; 1999 Aug; 54(2):146-52. PubMed ID: 10488741
    [Abstract] [Full Text] [Related]

  • 24. Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A.
    Irving WL, Jenkins RE, Walker PR, Clayden SA, Lydyard PM.
    Cell Immunol; 1985 Dec; 96(2):245-54. PubMed ID: 3017572
    [Abstract] [Full Text] [Related]

  • 25. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M, Samuel D, Amlot P, Panayi GS.
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [Abstract] [Full Text] [Related]

  • 26. Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis.
    Toussirot E, Wendling D, Tiberghien P, Luka J, Roudier J.
    Ann Rheum Dis; 2000 Jul; 59(7):533-8. PubMed ID: 10873963
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N, Roudier J.
    Joint Bone Spine; 2018 Mar; 85(2):165-170. PubMed ID: 28499895
    [Abstract] [Full Text] [Related]

  • 30. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.
    Tsoukas CD, Carson DA, Fong S, Slovin SF, Fox RI, Vaughan JH.
    Clin Immunol Immunopathol; 1982 Jul; 24(1):8-14. PubMed ID: 6179673
    [No Abstract] [Full Text] [Related]

  • 31. Immunoregulation in rheumatoid arthritis: evaluation of T lymphocyte function in the control of polyclonal immunoglobulin synthesis in vitro.
    Bellamy N, Cairns E, Bell DA.
    J Rheumatol; 1983 Feb; 10(1):19-27. PubMed ID: 6221098
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N, Roudier J, Roudier C.
    Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
    [Abstract] [Full Text] [Related]

  • 38. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M, Conway TF, Kelleher RJ, Sugiyama Y, Chen FA, Bankert RB, Bernstein SH.
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis.
    McChesney MB, Bankhurst AD.
    Ann Rheum Dis; 1986 Jul; 45(7):546-52. PubMed ID: 3017244
    [Abstract] [Full Text] [Related]

  • 40. Decreased T-cell-mediated suppression of IgM--rheumatoid factor synthesis in rheumatoid arthritis.
    Olsen NJ, Jasin HE.
    Clin Immunol Immunopathol; 1987 Jan; 42(1):38-49. PubMed ID: 2947767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.